Phase II
A disproportionate number of ALS patients on the investigational drug developed pneumonia.
Phase 1/2 trial to be HOOKIPA’s first clinical trial in immuno-oncology
In late June, Minovia Therapeutics dosed the first patient in a Phase I/II clinical trial with Pearson syndrome. The company is one of the first to make headway in treating rare mitochondrial diseases.
The beginning of virtual clinical trials is going to be a game-changer. Why they are going to be game-changer? What changes will occur? Know it all here.
It was a typically busy week for clinical trials, with announcements in a wide variety of indications. Here’s a look.
The companies indicate they hope to continue data analysis to better understand the disease and will present anything relevant at a future scientific meeting.
Companies from across Europe, Asia and around the globe share pipeline and business updates.
Medical Research Council (MRC) Grants Funding for Bermekimab as Part of its Support for “Outstanding Clinical Programs in the United Kingdom”
Engage Therapeutics, Inc. announced that data from a phase 2a study of Staccato® alprazolam to suppress seizures in patients with epilepsy were published in the peer-review journal Epilepsia.
Cara Therapeutics, Inc. announced the initiation of a Phase 2 trial of Oral KORSUVA for the treatment of pruritus in patients with atopic dermatitis.
PRESS RELEASES